Efficacy of Brodalumab in Patients with Psoriasis and Risk Factors for Treatment Failure: A Review of Post Hoc Analyses

By sjmartinez • September 13, 2024

Lebwohl MG, Armstrong AW, Alexis AF, Lain EL, Jacobson AA. Efficacy of Brodalumab in Patients with Psoriasis and Risk Factors for Treatment Failure: A Review of Post Hoc Analyses. Dermatol Ther (Heidelb). 2024 Sep 12. doi: 10.1007/s13555-024-01264-3. Epub ahead of print. PMID: 39264399.

Tags: Alcohol, biologic therapy, Dermatology, IL-17 receptor A inhibitor, Obesity, plaque psoriasis, Publications, Tobacco

Evidence of neuronal DNA damage in the brains of patients with Rett syndrome

Morales A, Korsakova E, Mansooralavi N, Soliman P, Jahanbani S, Olsen ML, Badhuri A, Lowry WE. Evidence of neuronal DNA damage in the brains of[...]

Multi-omics signature of healthy versus unhealthy lifestyles reveals associations with diseases

Fu G, Rushing BR, Graves L, Nieman DC, Pellegrini M, Soldano M, Thompson MJ, Sakaguchi CA, Pathmasiri W, Sumner SJ. Multi-omics signature of healthy versus[...]

Evaluating the impact of altitudinal variations on COVID-19 mortality rates: a comprehensive analysis

Karsli E, Metin DA, Kocatas A, Ercan FF, Sabirli R, Koseler A, Pellegrini M. Evaluating the impact of altitudinal variations on COVID-19 mortality rates: a[...]